Science Parks
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India.[1][2] It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing.[3][4][5] Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).[6]
History
Genome Valley was commissioned in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech International, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank.[7]
Alexandria Knowledge Park SEZ
In 2009, U.S.-based infrastructure giant Alexandria Real Estate Equities has announced its plans to invest in the bio-cluster, which led to the Alexandria Knowledge Park SEZ.[8] The bio-cluster at Shamirpet holds Certification mark by the United States Patent and Trademark Office and the European Union.[9]
IKP Knowledge Park
The IKP Knowledge Park is spread over 200 acres in Turakapally, is an initiative of ICICI Bank with five "innovation corridors" - a first of its kind knowledge-nurturing centre for Indian companies and a knowledge gateway for multinational companies".[10] The first phase of Innovation Corridor I, comprising 10 laboratories, around 3,000 ft² (300 m²) each, is operational and fully occupied. The second phase of Innovation Corridor I, comprising 16 laboratory modules of 1,700 ft² (170 m²) each, is ready for operation.
MN Park
In 2016, Mission Neutral Park has acquired specialized R&D assets in Genome Valley from U.S.-based Alexandria REIT and rechristened it as MN Park. It is a collaborative life sciences ecosystem in Genome Valley, Hyderabad consisting of Grade A R&D facilities.
MN Park is spread over 400 acres including build-up facilities of around 600,000 sq.ft. provided to global tenants like Novartis, GlaxoSmithKline, Mylan and Ashland Inc. MN’s focus area: Preleased industrial assets and specialized office spaces to sectors including specialized warehousing, logistics, food processing, light manufacturing, pharmaceutical R&D, biotechnology, etc.
